Clinical Trial Update: A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing gemcitabine and carboplatin with or without the investigational agent P276-00 in metastatic triple-negative breast cancer has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)
• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED